Citadel Advisors’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,506,602
| Closed | -$213M | – | 11880 |
|
|
2020
Q3 | $213M | Buy |
2,506,602
+479,427
| +24% | +$24.2M | 0.06% | 185 |
|
|
2020
Q2 | $71.8M | Sell |
2,027,175
-740,577
| -27% | -$21.7M | 0.03% | 575 |
|
|
2020
Q1 | $37.3M | Buy |
2,767,752
+2,525,137
| +1,041% | +$42.5M | 0.02% | 791 |
|
|
2019
Q4 | $5.13M | Sell |
242,615
-1,282,104
| -84% | -$22.6M | ﹤0.01% | 3048 |
|
|
2019
Q3 | $20.2M | Sell |
1,524,719
-1,712,968
| -53% | -$25.2M | 0.01% | 1460 |
|
|
2019
Q2 | $44.9M | Buy |
3,237,687
+3,175,235
| +5,084% | +$47.8M | 0.02% | 795 |
|
|
2019
Q1 | $1.2M | Sell |
62,452
-635,297
| -91% | -$10.2M | ﹤0.01% | 5258 |
|
|
2018
Q4 | $9.96M | Sell |
697,749
-501,129
| -42% | -$9.95M | 0.01% | 1896 |
|
|
2018
Q3 | $25M | Sell |
1,198,878
-520,832
| -30% | -$12.3M | 0.01% | 1222 |
|
|
2018
Q2 | $40.7M | Sell |
1,719,710
-101,687
| -6% | -$2.04M | 0.02% | 820 |
|
|
2018
Q1 | $26.6M | Sell |
1,821,397
-2,611,787
| -59% | -$42.7M | 0.01% | 921 |
|
|
2017
Q4 | $71.6M | Buy |
4,433,184
+3,270,177
| +281% | +$38.6M | 0.04% | 457 |
|
|
2017
Q3 | $16.3M | Buy |
+1,163,007
| New | +$11.6M | 0.01% | 1228 |
|
|
2017
Q2 | – | Sell |
-301,627
| Closed | -$2.12M | – | 8318 |
|
|
2017
Q1 | $1.95M | Buy |
+301,627
| New | +$1.53M | ﹤0.01% | 3105 |
|
|
2016
Q4 | – | Sell |
-23,227
| Closed | -$68.7K | – | 8104 |
|
|
2016
Q3 | $75K | Buy |
+23,227
| New | +$65K | ﹤0.01% | 6749 |
|
|
2016
Q2 | – | Sell |
-34,000
| Closed | -$114K | – | 7650 |
|
|
2016
Q1 | $85K | Sell |
34,000
-13,990
| -29% | -$31.5K | ﹤0.01% | 6088 |
|
|
2015
Q4 | $147K | Buy |
47,990
+19,795
| +70% | +$55.3K | ﹤0.01% | 6236 |
|
|
2015
Q3 | $48K | Buy |
+28,195
| New | +$72K | ﹤0.01% | 7618 |
|
|
2015
Q2 | – | Sell |
-21,384
| Closed | -$87.4K | – | 9251 |
|
|
2015
Q1 | $82K | Sell |
21,384
-18,102
| -46% | -$78.7K | ﹤0.01% | 7008 |
|
|
2014
Q4 | $190K | Sell |
39,486
-13,951
| -26% | -$55.1K | ﹤0.01% | 6032 |
|
|
2014
Q3 | $198K | Buy |
53,437
+9,382
| +21% | +$31.7K | ﹤0.01% | 5738 |
|
|
2014
Q2 | $161K | Sell |
44,055
-7,302
| -14% | -$26.8K | ﹤0.01% | 5807 |
|
|
2014
Q1 | $216K | Sell |
51,357
-200,499
| -80% | -$994K | ﹤0.01% | 5433 |
|
|
2013
Q4 | $1.16M | Buy |
251,856
+55,290
| +28% | +$246K | ﹤0.01% | 3083 |
|
|
2013
Q3 | $1.22M | Buy |
196,566
+20,907
| +12% | +$120K | ﹤0.01% | 2889 |
|
|
2013
Q2 | $956K | Buy |
+175,659
| New | +$577K | ﹤0.01% | 3229 |
|
Citadel Advisors's IMMU Position: Q4 2020 in Review
Citadel Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,506,602 shares — an estimated $213M sold.
Citadel Advisors first reported a position in IMMU in Q2 2013 and held it in 26 quarters. The position peaked at $213M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Citadel Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Citadel Advisors sold 2,506,602 Immunomedics Inc shares in Q4 2020, an estimated $213M.
- Citadel Advisors first reported a position in Immunomedics Inc in Q2 2013 and held it in 26 quarters.
- Citadel Advisors's Immunomedics Inc position peaked at $213M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.